Top Markets
#1 Black Phoenix Black Phoenix +199.93%
#2 Islamic Coin Islamic Coin +158.02%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.45%
#5 Akedo Akedo +35.05%
#6 BasedHype BasedHype +32.54%
#7 Acurast Acurast +26.15%
#8 Cryptopia Cryptopia +21.67%
#9 Quantum Resistant Ledger Quantum Resistant Ledger +17.60%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Cencora, Inc. Cencora, Inc.

Cencora, Inc.

COR
Rank in Stocks #415
Cencora, Inc. functions as a global leader in the sourcing and distribution of... Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Share Price
$313.20
Last synced: 2026-08-12
Market Cap
$60.94B
Change (1 day)
-5.93%
Change (1 year)
7.61%
Country
US
Trade Cencora, Inc. (COR)

Category

Healthcare
P/E ratio for Cencora, Inc. (COR)
P/E ratio as of 2026 TTM: 0
According to Cencora, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Cencora, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 22.16 -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 35.07 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 134.86 -
AU
Henry Schein, Inc. Henry Schein, Inc.
Henry Schein, Inc.
HSIC.US
 25.67 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.